Contact this trialFirst, we need to learn more about you.
Peptide
RLS-0071 for COPD
Recruiting0 awardsPhase 2
Saint Petersburg, Florida
This trial is studying a new treatment called RLS-0071 for adults with moderate exacerbations of COPD, which is a serious lung condition that can cause hospitalization and even death. Exacerb
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service